- Home
- CIG vs PTGX Comparison
CIG vs PTGX Comparison
Compare CIG & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIG | PTGX |
|---|---|---|
| Founded | 1952 | 2006 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CIG | PTGX |
|---|---|---|
| Price | $2.03 | $89.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $88.33 |
| AVG Volume (30 Days) | ★ 2.9M | 872.1K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.26 | ★ 0.72 |
| Revenue | ★ $7,960,960,695.00 | $209,217,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $296.47 |
| P/E Ratio | ★ $8.48 | $125.31 |
| Revenue Growth | ★ 9.92 | N/A |
| 52 Week Low | $1.59 | $33.70 |
| 52 Week High | $2.30 | $93.25 |
Technical Indicators
Market Signals| Indicator | CIG | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 65.20 |
| Support Level | $2.01 | $83.52 |
| Resistance Level | $2.16 | $90.85 |
| Average True Range (ATR) | 0.05 | 2.74 |
| MACD | -0.01 | -0.19 |
| Stochastic Oscillator | 19.35 | 68.00 |
Price Performance
Historical ComparisonAbout CIG Comp En De Mn Cemig ADS
Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.